QIAGEN has come to agreements with two US biotech companies to acquire worldwide exclusive rights to biomarkers that are expected to play an important role in personalized treatment of various cancers.
Read MoreA study supported by HHS could not validate or confirm previous research findings that suggested the presence of one of several viruses in blood samples of people living with chronic fatigue syndrome.
Read More
Molecular diagnostics has advanced in precision, accuracy, speed, and detection. There is much to commend, and much is to be done promising exciting health care solutions.
Read MoreA company spokeswoman attributes the shortage to the company’s inability to meet increasing demand and the transition to a new plant for bottling and labeling operations.
Read More
BioCare Medical LLC offers a new look at prostate cancer diagnosis.
Read More